A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice

Nature Medicine

Volumn 23, Issue 1, 2017, Pages 107-113

  Plovier, Hubert ^a   Everard, Amandine ^a   Druart, Céline ^a   Depommier, Clara ^a   Van Hul, Matthias ^a   Geurts, Lucie ^a   Chilloux, Julien ^b   Ottman, Noora ^c,e   Duparc, Thibaut ^d   Lichtenstein, Laeticia ^d   Myridakis, Antonis ^b   Delzenne, Nathalie M ^a   Klievink, Judith ^e   Bhattacharjee, Arnab ^e   Van Der Ark, Kees C H ^c   Aalvink, Steven ^c   Martinez, Laurent O ^d   Dumas, Marc Emmanuel ^b   Maiter, Dominique ^f   Loumaye, Audrey ^f   Hermans, Michel P ^f   Thissen, Jean Paul ^f   Belzer, Clara ^c   De Vos, Willem M ^c,e   Cani, Patrice D ^a   more..

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c WAGENINGEN UNIVERSITY   (Netherlands)

^d University Hospital of Toulouse   (France)

^e UNIVERSITY OF HELSINKI   (Finland)

^f CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; MEMBRANE PROTEIN; OXYGEN; RNA; UNSPECIFIC MONOOXYGENASE; GLUCOSE BLOOD LEVEL; TLR2 PROTEIN, HUMAN; TLR2 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 2;

AKKERMANSIA MUCINIPHILA; ANIMAL TISSUE; ARTICLE; BACTERIAL METABOLISM; BODY WEIGHT; CONTROLLED STUDY; DYSLIPIDEMIA; ENERGY ABSORPTION; FAT MASS; GENE; GENE CLUSTER; INSULIN RESISTANCE; INTESTINE; LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; METABOLIC SYNDROME X; METABOLOME; METABOLOMICS; MODULATION; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PASTEURIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERATURE; URINALYSIS; ADIPOSE TISSUE; ADULT; ANIMAL; DISEASE MODEL; DRUG EFFECTS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLISM; MIDDLE AGED; MOUSE MUTANT; RANDOMIZED CONTROLLED TRIAL; VERRUCOMICROBIA; WESTERN BLOTTING;

ADIPOSE TISSUE; ADULT; ANIMALS; BLOOD GLUCOSE; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; FEMALE; HUMANS; INSULIN RESISTANCE; INTESTINES; MALE; MEMBRANE PROTEINS; METABOLIC SYNDROME X; MICE, OBESE; MIDDLE AGED; OBESITY; TOLL-LIKE RECEPTOR 2; VERRUCOMICROBIA;

EID: 84997701899     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.4236     Document Type: Article

References (42)

1. Qin, J. et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55-60 (2012).
2. Le Chatelier, E. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541-546 (2013).
3. Forslund, K. et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528, 262-266 (2015).
4. Ridaura, V.K. et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science 341, 1241214 (2013).
5. Turnbaugh, P.J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444, 1027-1031 (2006).
6. Cani, P.D. et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 56, 1761-1772 (2007).
7. Everard, A. et al. Intestinal epithelial MyD88 is a sensor switching host metabolism towards obesity according to nutritional status. Nat. Commun. 5, 5648 (2014).
8. Everard, A. et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA 110, 9066-9071 (2013).
9. Derrien, M., Vaughan, E.E., Plugge, C.M. & de Vos, W.M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 54, 1469-1476 (2004).
10. Collado, M.C., Derrien, M., Isolauri, E., de Vos, W.M. & Salminen, S. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73, 7767-7770 (2007).
11. Derrien, M., Collado, M.C., Ben-Amor, K., Salminen, S. & de Vos, W.M. The mucin degrader Akkermansia muciniphila is an abundant resident of the human intestinal tract. Appl. Environ. Microbiol. 74, 1646-1648 (2008).
12. Dao, M.C. et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut 65, 426-436 (2016).
13. Shin, N.R. et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut 63, 727-735 (2014).
14. Org, E. et al. Genetic and environmental control of host-gut microbiota interactions. Genome Res. 25, 1558-1569 (2015).
15. Peng, G.C. & Hsu, C.H. The effcacy and safety of heat-killed Lactobacillus paracasei for treatment of perennial allergic rhinitis induced by house-dust mite. Pediatr. Allergy Immunol. 16, 433-438 (2005).
16. Sakai, T. et al. Lactobacillus plantarum OLL2712 regulates glucose metabolism in C57BL/6 mice fed a high-fat diet. J. Nutr. Sci. Vitaminol. (Tokyo) 59, 144-147 (2013).
17. Chevalier, C. et al. Gut microbiota orchestrates energy homeostasis during cold. Cell 163, 1360-1374 (2015).
18. Dumas, M.E. et al. Metabolic profling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. USA 103, 12511-12516 (2006).
19. Koeth, R.A. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576-585 (2013).
20. Bennett, B.J. et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 17, 49-60 (2013).
21. Miao, J. et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat. Commun. 6, 6498 (2015).
22. -/- mice. Circulation 133, 2434-2446 (2016).
23. Shi, H. et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J. Clin. Invest. 116, 3015-3025 (2006).
24. Abreu, M.T. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat. Rev. Immunol. 10, 131-144 (2010).
25. Vijay-Kumar, M. et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328, 228-231 (2010).
26. Reunanen, J. et al. Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of epithelial cell layer. Appl. Environ. Microbiol. 81, 3655-3662 (2015).
27. Ottman, N. et al. Characterization of outer membrane proteome of Akkermansia muciniphila reveals sets of novel proteins exposed to the human intestine. Front. Microbiol. 7, 1157 (2016).
28. Taniguchi, C.M., Emanuelli, B. & Kahn, C.R. Critical nodes in signalling pathways: insights into insulin action. Nat. Rev. Mol. Cell Biol. 7, 85-96 (2006).
29. Liu, Z. et al. High-fat diet induces hepatic insulin resistance and impairment of synaptic plasticity. PLoS One 10, e0128274 (2015).
30. Muccioli, G.G. et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol. Syst. Biol. 6, 392 (2010).
31. Cario, E., Gerken, G. & Podolsky, D.K. Toll-like receptor 2 controls mucosal infammation by regulating epithelial barrier function. Gastroenterology 132, 1359-1374 (2007).
32. Gu, M.J. et al. Barrier protection via Toll-like receptor 2 signaling in porcine intestinal epithelial cells damaged by deoxynivalnol. Vet. Res. 47, 25 (2016).
33. Cani, P.D. et al. Endocannabinoids-at the crossroads between the gut microbiota and host metabolism. Nat. Rev. Endocrinol. 12, 133-143 (2016).
34. Everard, A. et al. Microbiome of prebiotic-treated mice reveals novel targets involved in host response during obesity. ISME J. 8, 2116-2130 (2014).
35. Jones, M.L., Martoni, C.J., Di Pietro, E., Simon, R.R. & Prakash, S. Evaluation of clinical safety and tolerance of a Lactobacillus reuteri NCIMB 30242 supplement capsule: a randomized control trial. Requl Toxicol Pharmacol. 63, 313-320 (2012).
36. Burton, J.P. et al. Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem. Toxicol. 49, 2356-2364 (2011).
37. Wind, R.D., Tolboom, H., Klare, I., Huys, G. & Knol, J. Tolerance and safety of the potentially probiotic strain Lactobacillus rhamnosus PRSF-L477: a randomised, double-blind placebo-controlled trial in healthy volunteers. Br. J. Nutr. 104, 1806-1816 (2010).
38. Everard, A. et al. Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice. Diabetes 60, 2775-2786 (2011).
39. Brown, C.T. et al. Gut microbiome metagenomics analysis suggests a functional model for the development of autoimmunity for type 1 diabetes. PLoS One 6, e25792 (2011).
40. Png, C.W. et al. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105, 2420-2428 (2010).
41. Dona, A.C. et al. Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal. Chem. 86, 9887-9894 (2014).
42. + mutant of Yersinia enterocolitica serotype O:8 and its application in construction of rough mutants utilizing mini-Tn5 derivatives and lipopolysaccharide-specifc phage. J. Bacteriol. 176, 1756-1760 (1994).